• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tenaya Therapeutics Inc (NQ: TNYA )

    3.670 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.670
    Bid (Size) 1.470 (2)
    Ask (Size) 4.560 (1)
    Prev. Close 3.670
    Today's Range 3.670 - 3.670
    52wk Range 1.660 - 7.010
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    TNYA Stock Earnings: Tenaya Therapeutics Beats EPS for Q1 2024
    TNYA stock results show that Tenaya Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
    The company is hoping to take on Bristol Myers Squibb's Camzyos, a treatment for obstructive HCM. 
    Via Investor's Business Daily

    Performance

    YTD
    +13.98%
    +13.98%
    1 Month
    +18.77%
    +18.77%
    3 Month
    -17.16%
    -17.16%
    6 Month
    -22.57%
    -22.57%
    1 Year
    -25.86%
    -25.86%

    More News

    Read More
    TNYA Stock Earnings: Tenaya Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Expert Ratings for Tenaya Therapeutics
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Tenaya Therapeutics
    Via Benzinga
    Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Top 4 Health Care Stocks That Could Lead To Your Biggest Gains In Q3
    Via Benzinga
    Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    First Republic Bank, Activision Blizzard, Enphase Energy And Other Big Stocks Moving Lower On Wednesday
    Via Benzinga
    The 7 Best Biotech Stocks for Personalized Medicine Investors
    Via InvestorPlace
    3 Penny Stocks to Buy for 100% Returns
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why This Nasdaq Stock Caught Fire This Week
    Via The Motley Fool
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Dow Tumbles 150 Points; Tesla Shares Drop After Q1 Results
    Via Benzinga
    Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Tenaya Therapeutics, Clear Channel Outdoor And These 2 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.